title: [Comparison of the osteoprotective effects of orally administered equine conjugated estrogens and percutaneous 17 beta-estradiol].
authors.forename: J Y
authors.initials: JY
authors.lastname: Reginster
authors.forename: N
authors.initials: N
authors.lastname: Sarlet
authors.forename: R
authors.initials: R
authors.lastname: Deroisy
authors.forename: D
authors.initials: D
authors.lastname: Denis
authors.forename: M P
authors.initials: MP
authors.lastname: Lecart
authors.forename: P
authors.initials: P
authors.lastname: Franchimont
mesh_terms: D000279:Administration, Cutaneous; D000284:Administration, Oral; D001842:Bone and Bones / Q000187:drug effects* / Q000378:metabolism; D004958:Estradiol / Q000008:administration & dosage*; D004966:Estrogens, Conjugated (USP) / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D008593:Menopause; D008875:Middle Aged; D010024:Osteoporosis / Q000517:prevention & control*
chemical_list: D004966:Estrogens, Conjugated (USP); D004958:Estradiol
vernacular_title: Comparaison de l'effet ostéoprotecteur des oestrogènes conjugués équins administrés par voie orale et du 17 beta-oestradiol percutané.